Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Foghorn Therapeutics Inc (NQ: FHTX )

13.04 -0.88 (-6.32%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 28, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 45,192
Open 14.09
Bid (Size) 9.170 (1)
Ask (Size) 29.70 (1)
Prev. Close 13.92
Today's Range 12.82 - 14.22
52wk Range 8.010 - 24.34
Shares Outstanding 36,936,886
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
58 Biggest Movers From Yesterday
Gainers Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 234.2% to close at $1.27 after the company announced it sold its complement portfolio for $60 million. 
Via Benzinga
Mid-Afternoon Market Update: Nasdaq Gains 150 Points; Copper Up 1.5%
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 600 points on Monday. 
Via Benzinga

Performance

YTD
-37.07%
-37.07%
1 Month
+1.09%
+1.09%
3 Month
-8.23%
-8.23%
6 Month
-38.43%
-38.43%
1 Year
+29.75%
+29.75%

More News

Read More
FDA Places Clinical Hold On Foghorn Therapeutics' Early-Stage Blood Cancer Trial
Via Benzinga
Mid-Day Market Update: Dow Rises Over 600 Points; O2Micro International Shares Surge
Via Benzinga
30 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Mid-Day Market Update: Dow Tumbles 200 Points; TherapeuticsMD Shares Jump
Via Benzinga
66 Biggest Movers From Friday
Via Benzinga
38 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Mid-Morning Market Update: Markets Open Higher; Deere Tops Q2 Views
Via Benzinga
The Daily Biotech Pulse: CDC Recommends COVID-19 Boosters For Kids 5-11, Foghorn's Blood Cancer Trial On Clinical Hold, Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara
Via Benzinga
10 Biggest Price Target Changes For Friday
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
95 Biggest Movers From Friday
Via Benzinga
50 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
34 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
20 Stocks Moving in Tuesday's Pre-Market Session
Via Benzinga
FHTX Stock Alert: 7 Things to Know About the Partnership Lifting Foghorn Today
Via InvestorPlace
Mid-Afternoon Market Update: Dow Tumbles Over 200 Points; BELLUS Health Shares Spike Higher
Via Benzinga
58 Biggest Movers From Yesterday
Via Benzinga
Mid-Day Market Update: Nasdaq Drops Over 100 Points; Foghorn Therapeutics Shares Surge
Via Benzinga
Topics Stocks
Exposures US Equities
40 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Mid-Morning Market Update: Markets Open Lower; Pfizer To Acquire Arena Pharmaceuticals
Via Benzinga
Topics Stocks
Exposures US Equities
Foghorn Therapeutics Stock Surges After $1.5B Cancer Pact With Eli Lilly
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.